Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Biomedical Science · India · 2025-03-11

Processing Time
468 days
Decision Date
2025-03-11
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate how human tonsillar immune cells respond to infections like Kaposi Sarcoma herpesvirus (KSHV) to develop therapeutic interventions and vaccines that prevent viral infections from progressing into cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the public health burden of virus-associated cancers, which is a core priority for U.S. biomedical research.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a documented history of impactful research with 357 citations and peer-review experience.

3 Balance of Factors Met

Given the petitioner's specialized skills and the potential for tangible health benefits, it is beneficial to the U.S. to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved because the petitioner demonstrated significant influence in the field through 11 peer-reviewed journal articles and 357 citations. Additionally, the petitioner's expertise was validated by performing at least 7 peer reviews for scientific journals, satisfying the requirements for a National Interest Waiver.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 591 days 2025-11-27
The petitioner proposes to continue her research in biomedical science, specifically focusing on uncovering the mechanisms of disease-causing viruses and tuberculosis to identify how they operate and can be more effectively treated. Her work involves investigating viral mechanisms, immune responses, and therapeutic pathways to develop novel antiviral treatments and nonviral delivery platforms.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Pennsylvania 64 days 2025-11-26
The petitioner proposes to continue research on the fundamental mechanisms of cellular stress response and immune system function to advance vaccine development and biotherapeutics. The work utilizes antibody engineering and advanced sequencing technologies to create practical innovations for protecting vulnerable populations from respiratory infections. The intended impact is to address nationwide public health challenges and improve national health security through immediate therapeutic potential.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Ohio 90 days 2025-01-24
The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 468 days
Criteria Met 3 / 3
Evidence Types 3

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist